How RTPM data reveals medication risk in insurance claims
Understanding what real-time prescription monitoring data tells you about medication-related risk, clinical appropriateness, and claim complexity in insurance assessments.
Published 3 April 2026
What RTPM data reveals that traditional claims assessment misses
Real-time prescription monitoring (RTPM) data provides insight into medication use patterns that traditional claims assessment alone cannot access. When you rely on claimant self-report, treating doctor information, and pharmacy records submitted with claims, you're seeing a fragmented picture. RTPM systems like QScript, ScriptCheckSA, ScriptCheckWA, TasScript, NTScript, and CanberraScript give you complete, objective, real-time visibility into what medications your claimant is actually accessing across all pharmacies in their jurisdiction.
This matters because medication-related risks are often hidden in claims. Your claimant may not mention all their medications. Treating doctors may not know about prescriptions from other practitioners. Pharmacy records you receive may be incomplete. But RTPM data doesn't lie about what was dispensed, when, and in what quantities.
The clinical patterns RTPM data identifies
When you refer RTPM data for medication review, specialists look for specific patterns that indicate medication risk:
Multiple prescribers pattern
If your claimant is seeing three or more doctors for pain management without apparent coordination, RTPM data will show that pattern clearly. This may indicate legitimate complex care needs, but it's also a red flag for doctor shopping, where patients seek prescriptions from multiple providers without informing each prescriber about other medications they're receiving.
High-dose regimens
RTPM data reveals dose patterns over time. If your claimant is on high-dose opioids, benzodiazepines, or other controlled substances, or if doses are escalating rapidly, that's a medication risk signal. These patterns often precede serious complications like overdose, dependence, or falls.
Dangerous combinations
Some medication combinations carry serious risks. The combination of opioids plus benzodiazepines substantially increases overdose and respiratory depression risk. The combination of opioids plus certain antihistamines or antipsychotics increases fall risk. RTPM data makes these dangerous combinations visible in a way that individual pharmacy records alone might not.
Inconsistent medication use
If RTPM data shows your claimant is getting prescriptions filled erratically (gaps followed by refills), using multiple pharmacies to obscure total quantities, or obtaining prescriptions for medicines that seem unrelated to their claimed injury, these patterns warrant closer assessment.
Dose tapering or cessation
Positive medication patterns also appear in RTPM data. If your claimant's doses are decreasing or medicines are being ceased, that indicates improvement and recovery. This is clinically valuable information for your recovery timeline and return-to-work planning.
Why RTPM patterns matter for claim risk
Medication-related patterns in RTPM data correlate with significant claim risks:
| RTPM Pattern | Clinical Risk | Claim Cost Impact | Management Priority |
|---|---|---|---|
| Opioids beyond 12 weeks | Dependence, tolerance, overdose risk | Ongoing medication costs, potential complications, extended recovery | High |
| Opioid + benzodiazepine combination | Overdose, respiratory depression, fall risk | Hospitalisation, emergency department use, critical injury risk | Critical |
| Multiple high-dose prescribers | Uncoordinated care, duplications, interactions | Preventable complications, extended liability | High |
| Rapid dose escalation | Tolerance, medication-seeking behaviour | Escalating medication costs, potential for abuse/diversion | Medium |
| Doses decreasing/cessation | Recovery, improving functional capacity | Positive cost trajectory, supports claim closure | Low (positive indicator) |
Translating RTPM patterns into claim action
RTPM data alone is a risk signal, not a diagnosis or definitive answer. Your next step is to refer for specialist medication review. When you refer RTPM data to IMM, we combine that data with clinical assessment to provide actionable intelligence about your claimant's medication risk. We assess whether the medications are clinically appropriate for the injury, whether doses are within evidence-based guidelines, whether prescribing is coordinated, and what specific risks require intervention.
Early intervention opportunities
RTPM data helps you identify medication risks early, before expensive complications develop. If RTPM shows your claimant is on high-dose opioids or benzodiazepines, a pharmacist-led medication review now can prevent overdose, dependence, or falls later. This is proactive risk management that improves outcomes and reduces costs.
Treatment plan optimization
If RTPM data shows your claimant is on multiple medicines without clear coordination, a specialist review can help consolidate treatment, reduce duplications, and improve adherence. Better-managed medication regimens mean better recovery, faster return to work, and reduced claim duration.
Return-to-work planning informed by medication reality
RTPM data tells you what your claimant is actually taking, not what they think they're taking or what they report. This allows you to set realistic return-to-work timelines that account for actual medication impacts on work capacity. If your claimant is on high-dose sedating medications, their actual work capacity is limited by medication effects, not just the injury.
RTPM data and contested claims
In disputed claims, RTPM data is objective, court-admissible evidence of medication use. It overcomes "he said, she said" disputes about what medications were necessary, how long they've been used, and whether use is consistent with injury severity. This objectivity is particularly valuable in claims where liability, causation, or ongoing necessity is contested.
The bottom line: RTPM data as a risk management tool
RTPM data is not a replacement for clinical judgment or comprehensive medication review. But it is a powerful risk identification tool. When integrated with specialist clinical assessment, RTPM data allows you to identify medication risks early, intervene before complications develop, and make better-informed decisions about claim progression and settlement. Your medication risk management is only as good as your data. RTPM gives you the best data available.
Want to use RTPM data to improve your medication risk management?
IMM's specialists help you interpret RTPM data and translate medication risk signals into actionable clinical intelligence that improves your claims management and outcomes.
Request a Medication Review
